## EquityIncentivePlansTables

**Year Ended**

|  | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| --- | --- | --- | --- |
| **  Summary of Stock Option and RSU Activity** | The following table summarizes our stock option and RSU activity for the year 
ended December 31, 2023:

                                                       Stock Options            
RSUs              
                                                           Number of      
Weighted-         Weighted-                         Number              
  Beginning of period                                        343,564         
$30.65                                           21,333      162.32  
  Granted                                                      9,521        
$226.50                                           11,743      228.33  
  Exercised or released                                      (7,626)         
$43.07                                         (11,085)      116.47  
  Cancelled                                                  (1,438)        
$194.23                                          (2,903)      192.22  
  End of period                                              344,021         
$35.11              4.31      73.57              19,088      225.01  
  Vested and expected to vest, December 31, 2023             340,884         
$33.38              4.27      73.45              18,446      225.76  
  Exercisable and vested, December 31, 2023                  329,124         
$27.07              4.11      72.90
 |  |  |
| **  Schedule of Fair Value of Stock Option Award and ESPP on Grant Date** | The weighted-average assumptions used in the Black-Scholes model for stock 
options are as follows:

                                       Year Ended December 31,                  
                                                          2023      2022      
2021  
 ───────────────────────────────────────────────────────────────────────────────
─────
  Risk-free interest rate                                 3.90      3.11      
0.66  
  Expected term (in years)                                 4.5       4.1       
4.3  
  Expected volatility                                       63        63        
59  
  Dividend yield                                           0.0       0.0       
0.0  
  Grant date fair value per share                            $         $        
$
 |  |  |
| **  Summary of Operational Milestone Based on Revenue or Adjusted EBITDA** | The achievement status of the operational milestones as of December 31, 2023 is 
provided below.

  Total Annualized Revenue                              Annualized Adjusted 
EBITDA                          
                 Milestone      Achievement Status                       
Milestone      Achievement Status  
                     $20.0      Achieved                                      
$1.5      Achieved            
                     $35.0      Achieved                                      
$3.0      Achieved            
                     $55.0      Achieved                                      
$4.5      Achieved            
                     $75.0      Achieved                                      
$6.0      Achieved            
                    $100.0      -                                             
$8.0      Achieved            
                    $125.0      -                                            
$10.0      Achieved            
                    $150.0      -                                            
$12.0      Achieved            
                    $175.0      -                                            
$14.0      Achieved
 |  |  |
| **  Summary of Stock-Based Compensation Expense** | The following table summarizes our stock-based compensation expense by line item
in the consolidated statements of operations (in millions):

                                           Year Ended December 31,              
                                           2023                                 
2022                 2021             
 ───────────────────────────────────────────────────────────────────────────────
──────────────────────────────────────────
  Cost of revenues                         $                              741   
$           594      $           421  
  Research and development                 689                                  
536                  448              
  Selling, general and administrative      382                                  
430                            1,252  
  Total                                    $                            1,812   
$         1,560      $         2,121
 |  |  |